Biologics & Bioprocessing
Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Biologics, Bioprocessing & Biobanking
Bio Banks / Bio Repositories
Barcode Labellers (1)
Cryopreservation, Cyrovials & Storage (13)
Gene Bank (0)
Tissue Banking (0)
Data Analysis (2)
Enzymes & Enzyme Function (0)
Gene Regulation (0)
Human Gene Mutation (0)
Next Generation Sequencing (0)
Protein databases (1)
Bioprocess Equipment, Reagents & Consumables
Bioreactors / Fermentors (0)
Buffers & Process Liquids (0)
Cell Culture Reagents & Supplements (0)
Contaminant Detection (1)
Filtration Systems (0)
Serum-Free Media (0)
Bioprocessing / Biomanufacturing
Assay & Analytical Services (0)
Clinical Production (0)
Contract Research (2)
Process Development (1)
Production Testing (0)
Protein Aggregation (0)
Protein Expression (0)
Raman Spectroscopy (0)
Sample Coordination & Distribution (0)
Scale-up & Technology Transfer (4)
Toll Processing (0)
Vector & Cell Line Development (0)
Cloning & Expression (0)
Gene Expression Analysis (1)
Genomic Services (0)
Genotyping Technologies (0)
Molecular Biology (0)
Real-Time PCR (6)
Nucleic Acid (0)
Peptides & Antibodies (0)
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,300+ scientific and medical posters
4,900+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!